Stockreport

Immunome: Enthusiasm For New Management Has Faded [Seeking Alpha]

Immunome, Inc.  (IMNM) 
PDF The company's new CEO has drawn attention to the company, which has one asset, AL102, in clinical evaluation for desmoid tumors. Immunome also has a collaboration wit [Read more]